Mills K J, Smart R C
Toxicology Program, North Carolina State University, Raleigh 27695-7633.
Carcinogenesis. 1989 May;10(5):833-8. doi: 10.1093/carcin/10.5.833.
The purpose of this study was to examine the activity and associated kinetic parameters of epidermal protein kinase C (PKC) following stimulation by sn-1,2-dioctanoylglycerol (DIC8) or 12-O-tetradecanoylphorbol-13-acetate (TPA) and to examine the relationship between levels of epidermal PKC activity and the induction of ornithine decarboxylase by these agents, utilizing various stocks and strains of mice. Importantly, the mouse strains and stock used in this study have known differing susceptibilities to undergo TPA-induced tumor promotion: the CD-1 stock and the DBA/2 strain (both sensitive to TPA-induced tumor promotion) and the C57BL/6 strain (resistant to TPA-induced tumor promotion). TPA-stimulated protein kinase C activity was measured in the 10(5)g supernatant fraction of epidermal homogenates using lysine-rich histone as a phosphate acceptor substrate. The maximal velocities for TPA-stimulated epidermal PKC activity in CD-1, DBA/2 and C57BL/6 were 0.28, 0.29 and 0.27 nmol PO4-histone/mg 10(5)g protein/min, respectively. TPA-stimulated epidermal PKC from CD-1, DBA/2 and C57BL/6 had similar theoretical Vmax values and the apparent concentrations of TPA yielding half-maximal stimulation of PKC were also similar. DiC8-stimulated PKC activity to a greater Vmax; however, the concentration required to yield half-maximal stimulation of PKC was one thousand times greater than that of TPA. There were no strain differences in these parameters when the enzyme was stimulated with DiC8. Thus, the levels of epidermal PKC activity in CD-1, DBA/2 and C57BL/6 mice exhibit no strain differences when stimulated by TPA or DiC8 using lysine-rich histone as a phosphate acceptor substrate. Since sn-1,2-diacylglycerols are known effective inducers of epidermal ornithine decarboxylase (ODC) activity, the induction of epidermal ODC was examined in each mouse strain 5 h after topical application of 2 nmol TPA, 5 nmol TPA or 2.5 mumol DiC8. After topical treatment with TPA, C57BL/6 demonstrated an unexpected 2- and 4-fold increase in ODC activity over CD-1 and DBA/2 mice. After treatment with DiC8, C57BL/6 demonstrated a 6- and 10-fold increase in ODC activity over CD-1 and DBA/2, respectively. Thus, the resistant strain (C57BL/6) demonstrated a 'hyperinducibility' of epidermal ODC activity by TPA or DiC8. The time course for the induction of epidermal ODC was examined in each strain, and at every time point measured (3-15 h), the C57BL/6 strain exhibited this 'hyperinducibility' of ODC relative to the other strains. Epidermal DNA synthesis was stimulated to a similar extent in C57BL/6 and CD-1 mice.(ABSTRACT TRUNCATED AT 400 WORDS)
本研究的目的是检测在经sn-1,2-二辛酰甘油(DIC8)或12-O-十四酰佛波醇-13-乙酸酯(TPA)刺激后,表皮蛋白激酶C(PKC)的活性及相关动力学参数,并利用不同品系和种群的小鼠检测表皮PKC活性水平与这些试剂诱导鸟氨酸脱羧酶之间的关系。重要的是,本研究中使用的小鼠品系和种群对TPA诱导的肿瘤促进作用具有已知的不同易感性:CD-1种群和DBA/2品系(均对TPA诱导的肿瘤促进作用敏感)以及C57BL/6品系(对TPA诱导的肿瘤促进作用有抗性)。使用富含赖氨酸的组蛋白作为磷酸受体底物,在表皮匀浆的10(5)g上清液组分中测量TPA刺激的蛋白激酶C活性。在CD-1、DBA/2和C57BL/6中,TPA刺激的表皮PKC活性的最大速度分别为0.28、0.29和0.27 nmol PO4-组蛋白/mg 10(5)g蛋白/分钟。来自CD-1、DBA/2和C57BL/6的TPA刺激的表皮PKC具有相似的理论Vmax值,且产生PKC半最大刺激的TPA表观浓度也相似。DIC8刺激PKC活性达到更高的Vmax;然而,产生PKC半最大刺激所需的浓度比TPA高一千倍。当用DIC8刺激该酶时,这些参数没有品系差异。因此,当使用富含赖氨酸的组蛋白作为磷酸受体底物,经TPA或DIC8刺激时,CD-1、DBA/2和C57BL/6小鼠的表皮PKC活性水平没有品系差异。由于已知sn-1,2-二酰甘油是表皮鸟氨酸脱羧酶(ODC)活性的有效诱导剂,在局部应用2 nmol TPA、5 nmol TPA或2.5 μmol DIC8 5小时后,检测了每个小鼠品系中表皮ODC的诱导情况。经TPA局部治疗后,C57BL/6小鼠的ODC活性比CD-1和DBA/2小鼠意外地增加了2倍和4倍。用DIC8治疗后,C57BL/6小鼠相对于CD-1和DBA/2小鼠的ODC活性分别增加了6倍和10倍。因此,抗性品系(C57BL/6)对TPA或DIC8表现出表皮ODC活性的“超诱导性”。检测了每个品系中表皮ODC诱导的时间进程,在测量的每个时间点(3 - 15小时),C57BL/6品系相对于其他品系均表现出ODC的这种“超诱导性”。C57BL/6和CD-1小鼠的表皮DNA合成受到的刺激程度相似。(摘要截断于400字)